Cardiol Therapeutics (CRDL) Stock Price, Quote, News & History | Benzinga

Cardiol Therapeutics Inc (CRDL) Stock Price, Quote, News & History

CRDLNASDAQ

Trade with Public

Trade with Public

$1.91

0.0150.79%

Last update: Aug 19, 9:28 AM

Earnings: Q2 2026 Earnings were released on Wed Aug 12th, after the market close

OverviewNews Earnings Forecast Events Price Targets Financials Sentiment Compare Options Stock Report

Key Statistics

Open

$1.92

Close

-

Volume / Avg.

1.36M / 718.31K

Day Range

$1.86 - $1.97

52 Wk Range

0.88 - 1.94

Market Cap

$223.13M

P/E Ratio

-

Dividend Yield

-

Exchange

NASDAQ

RSI

87

Short Interest

1.98%

Days to Cover

2.29

Recent Cardiol Therapeutics Inc News

Why MongoDB Shares Are Trading Higher By Over 22%; Here Are 20 Stocks Moving Premarket

Avi Kapoor

This Visa Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Monday

Avi Kapoor

3 Penny Stocks Ready to Break Out in 2025

Known for their uncommonly pronounced risk/reward profile, penny stocks all too often entice investors with their low prices and potential for significant returns, only to fail to live up to those expectations. The

MarketBeat

CBD-Based Drug Reduces Pericarditis Pain And Inflammation, Shows New Clinical Study

Nina Zdinjak

Why Cardiol Therapeutics (CRDL) Stock Is Down 20% Today

Cardiol Therapeutics shares are trading lower by 20% Wednesday morning. The company announced a $13.5 million public offering.

Henry Khederian

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Cash Flows

Operating Cash Flow (TTM)

-24.05M

Investing Cash Flow (TTM)

-56.72K

Financing Cash Flow (TTM)

31.61M

Free Cash Flow (TTM)

-24.10M

Capital Expenditure (TTM)

-56.72K

Net Change in Cash (TTM)

7.51M

Analyst Trends and Forecast

1

Apr

1

Jul

1

Aug

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

4.0

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Valuation Metrics

Enterprise Value

$201.09M

PE Ratio (TTM)

-

PE Ratio (FWD)

-

PEG Ratio (TTM)

-

PS Ratio (TTM)

-

PB Ratio (TTM)

12.82

Earnings Yield % (TTM)

-12.90%

Earnings Yield % (FWD)

-12.14%

EV / EBITDA (TTM)

-

Price / EBITDA (TTM)

-

Price / Free Cash Flow (TTM)

-

Book Value / Share

$0.15

Company Debt

Total Debt

-

LT Debt

-

LT Debt Issuance (TTM)

-

LT Debt Repayment (TTM)

-$55.38K

Total Cash

$26.08M

Debt to Equity

0.00

Issuance of Debt (TTM)

-$55.38K

Repayment of Debt (TTM)

-$55.38K

Key Statistics

Open

$1.92

Close

-

Volume / Avg.

1.36M / 718.31K

Day Range

$1.86 - $1.97

52 Wk Range

0.88 - 1.94

Market Cap

$223.13M

P/E Ratio

-

Dividend Yield

-

Exchange

NASDAQ

RSI

87

Short Interest

1.98%

Days to Cover

2.29

About

Sector

Health Care

Industry

Pharmaceuticals

Cardiol Therapeutics Inc is a late-stage life sciences company focused on advancing the development of anti-inflammatory and anti-fibrotic therapies for heart disease. Its primary small-molecule candidate, CardiolRx, targets inflammasome pathway acti...

Show More

Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

Q

How do I buy Cardiol Therapeutics (CRDL) stock?

A

You can purchase shares of Cardiol Therapeutics (NASDAQ:CRDL) through any online brokerage.

View our list of the best stock brokerages

Q

Who are Cardiol Therapeutics (CRDL) competitors?

A

Other companies in Cardiol Therapeutics’s space includes: Eli Lilly and Co (NYSE:LLY), Johnson & Johnson (NYSE:JNJ), Merck & Co Inc (NYSE:MRK), Novartis AG (NYSE:NVS) and AstraZeneca PLC (NYSE:AZN).

Q

What is the forecast, or price target, for Cardiol Therapeutics (CRDL) stock?

A

Cardiol Therapeutics has a consensus price target of $9.50.

Q

What is the current price for Cardiol Therapeutics (CRDL)?

A

The stock price for Cardiol Therapeutics (NASDAQ: CRDL) is $1.91 last updated August 19, 2026 at 9:28 AM EDT.

Q

Does Cardiol Therapeutics (CRDL) pay a dividend?

A

There are no upcoming dividends for Cardiol Therapeutics.

Q

When is Cardiol Therapeutics (NASDAQ:CRDL) reporting earnings?

A

Cardiol Therapeutics does not have any upcoming earnings scheduled.

Q

Is Cardiol Therapeutics (CRDL) going to split?

A

There is no upcoming split for Cardiol Therapeutics.

Q

What sector and industry does Cardiol Therapeutics (CRDL) operate in?

A

Cardiol Therapeutics is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.